Access Pharma's Prospects Look Good Even Without a Buyout

An email from 'Marty' regarding Access Pharmaceuticals (ACCP.OB):

What's your take on Access Pharma?...I'm hearing lots of takeover rumors but that's not enough to warrant a strong position. What are its prospects as a stand-alone and what are your thoughts about a possible buy out?

VFC's Take: I think you hit the nail on the head regarding a takeover; it's nice to speculate on a buyout, but that alone does not warrant a large position.

That being said I think that Access has a lot of potential, as a business and as an investment. Additionally, the company got some big publicity in the form of a feature in this week's issue of Business Week, so it's possible that the stock could trade up a bit as new investors are lured in by the publicity look to gain a position in the stock.

With a market cap of thirty six million, this stock has room to move - even after the run over the past few months. As for the buyout, I wouldn't invest solely in anticipation of a buyout, but if it happens, take it as a nice bonus.

Disclosure: No position.

Comments

[mrtaxx:]

What a rediculous uninformative report, you apparently like the stock but give no facts as to why. People like you should never give stock advice if your going to give your personal opinion with no factual backup . When someone asks you a question it should be answered with facts not just your opinion. Take off your sunglasses, get out of your hammock, loose some weight and do some DD.

Oct 05 04:49 AM

[VFC's Stock...:]

Someone woke up on the bitter side of the bed, eh?

Oct 05 07:04 AM

[User 401079:]

For more detailed information on ACCP see Mike Havrilla posts here on SA. Thanks.

Oct 05 08:40 AM

[Roy Manning:]

The market cap on ACCESS is worth about $80 million because they have alot of outstanding warrants. I own alot of ACCP since I see MuGard and a potential billion dollar drug. MuGard has been approved in US, Europe and Asia. ACCP second drug Prolindac is in stage II combination trials with other cancer drugs.

Oct 05 09:27 AM